Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Prepulse Inhibition of Startle in Cocaine Dependence - 7 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from NIDA evaluating prepulse inhibition of startle in cocaine use disorder, with the study (NCT00015249) now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders, Substance-Related Disorders | Phase 1 | Status: COMPLETED